[
  {
    "ts": null,
    "headline": "Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks",
    "summary": "BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.",
    "url": "https://finnhub.io/api/news?id=98bfc53e3e88e832edce740a1001aa91c4ea9e903cdab2f7ec9ec0dc5c792cdf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749047460,
      "headline": "Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks",
      "id": 135010949,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.",
      "url": "https://finnhub.io/api/news?id=98bfc53e3e88e832edce740a1001aa91c4ea9e903cdab2f7ec9ec0dc5c792cdf"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Amgen Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 09",
    "summary": "Presenter SpeechMichael Yee Good morning, everyone. I'm Michael Yee, Senior Biotechnology Analyst here at Jefferies. And very excited to continue on with our next fireside discussion here at the...",
    "url": "https://finnhub.io/api/news?id=c690320503d3822e5b3d453196a0ffd6f04464ef6e8075a78e9a3cafdff1e62a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749040533,
      "headline": "Transcript : Amgen Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 09",
      "id": 135011815,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "Presenter SpeechMichael Yee Good morning, everyone. I'm Michael Yee, Senior Biotechnology Analyst here at Jefferies. And very excited to continue on with our next fireside discussion here at the...",
      "url": "https://finnhub.io/api/news?id=c690320503d3822e5b3d453196a0ffd6f04464ef6e8075a78e9a3cafdff1e62a"
    }
  },
  {
    "ts": null,
    "headline": "Amgen: Tariff And Drug Pricing Remain Key Uncertainties",
    "summary": "Amgen: Tariff And Drug Pricing Remain Key Uncertainties",
    "url": "https://finnhub.io/api/news?id=d85a757d1283be04326ed6c9ec9048ba808463c0951a8745e8d9e3414a5188cd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749039979,
      "headline": "Amgen: Tariff And Drug Pricing Remain Key Uncertainties",
      "id": 135011562,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=d85a757d1283be04326ed6c9ec9048ba808463c0951a8745e8d9e3414a5188cd"
    }
  },
  {
    "ts": null,
    "headline": "HQL: Positive Outlook Due To Increased Healthcare Spending",
    "summary": "I maintain my buy rating on HQL due to its attractive 14% yield, discounted valuation, and long-term healthcare growth outlook.",
    "url": "https://finnhub.io/api/news?id=9031a7d42b96b38ba58b6b3765f535e4c89326fde198576909e01b7d1ffe4747",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749030762,
      "headline": "HQL: Positive Outlook Due To Increased Healthcare Spending",
      "id": 135009522,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1432883724/image_1432883724.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "I maintain my buy rating on HQL due to its attractive 14% yield, discounted valuation, and long-term healthcare growth outlook.",
      "url": "https://finnhub.io/api/news?id=9031a7d42b96b38ba58b6b3765f535e4c89326fde198576909e01b7d1ffe4747"
    }
  },
  {
    "ts": null,
    "headline": "ASCO 2025: DeLLphi-304 helps Amgen to pave the way for BiTEs in solid cancers",
    "summary": "Imdelltra is a BiTE that targets DLL3 and CD3 receptors.",
    "url": "https://finnhub.io/api/news?id=3d8c7dd7e8a91f553ea6978c8710c264b61423eded23b463fe15e0ce608177e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749030744,
      "headline": "ASCO 2025: DeLLphi-304 helps Amgen to pave the way for BiTEs in solid cancers",
      "id": 135010950,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Imdelltra is a BiTE that targets DLL3 and CD3 receptors.",
      "url": "https://finnhub.io/api/news?id=3d8c7dd7e8a91f553ea6978c8710c264b61423eded23b463fe15e0ce608177e4"
    }
  }
]